Obstetrics and Gynecologist
Reproductive Geneticist
IVF Florida Reproductive Associates, Margate, Florida
Dr. Rivera-Cruz is an obstetrician and gynecologist with a passion for the reproductive genetics field. She is currently a third year genetics fellow with an interest in the reproductive endocrinology and infertility field.
She attended the University of Puerto Rico from 2007-2011 where she got her bachelor’s degree in Natural Sciences. She then went to Universidad Central del Caribe School of Medicine from 2011-2015 where she started developing her interest in Ob-Gyn and reproductive medicine. She was selected as a member of Alpha-Omega-Alpha Honor Medical Society. In 2015, Dr. Rivera-Cruz earned her medical degree. She then continued her training in Obstetrics and Gynecology at the University of Puerto Rico, Medical Science Campus (ACGME program). In 2019, Dr. Rivera-Cruz finished her Ob-Gyn training where she served as chief resident and was recognized by her excellence in Female Pelvic Medicine and Reconstructive Surgery as well as in Minimally Invasive Gynecological Surgery. During her residency, she discovered her true passion while taking care of patients with genetic disorders that predispose them to infertility. For this reason, Dr. Rivera-Cruz, continued her training in medical genetics and genomics at Boston Children’s Hospital, Harvard Medical School Genetics Program where she developed an interest in Turner syndrome. She developed a study to describe the methods of conception, maternal and neonatal outcomes in women with TS and how these outcomes differ between women with mosaicism.
As a Hispanic and Latina physician, Dr. Rivera-Cruz has the ambition to provide care for racial and ethnic minority groups and to have an impact within the Hispanic community. She would like to be an advocate from her community by improving healthcare access, medical care and at the same time improving Latinx research representation in reproductive medicine.
Obstetrics and Gynecologist
Reproductive Geneticist
IVF Florida Reproductive Associates, Margate, Florida
Dr. Rivera-Cruz is an obstetrician and gynecologist with a passion for the reproductive genetics field. She is currently a third year genetics fellow with an interest in the reproductive endocrinology and infertility field.
She attended the University of Puerto Rico from 2007-2011 where she got her bachelor’s degree in Natural Sciences. She then went to Universidad Central del Caribe School of Medicine from 2011-2015 where she started developing her interest in Ob-Gyn and reproductive medicine. She was selected as a member of Alpha-Omega-Alpha Honor Medical Society. In 2015, Dr. Rivera-Cruz earned her medical degree. She then continued her training in Obstetrics and Gynecology at the University of Puerto Rico, Medical Science Campus (ACGME program). In 2019, Dr. Rivera-Cruz finished her Ob-Gyn training where she served as chief resident and was recognized by her excellence in Female Pelvic Medicine and Reconstructive Surgery as well as in Minimally Invasive Gynecological Surgery. During her residency, she discovered her true passion while taking care of patients with genetic disorders that predispose them to infertility. For this reason, Dr. Rivera-Cruz, continued her training in medical genetics and genomics at Boston Children’s Hospital, Harvard Medical School Genetics Program where she developed an interest in Turner syndrome. She developed a study to describe the methods of conception, maternal and neonatal outcomes in women with TS and how these outcomes differ between women with mosaicism.
As a Hispanic and Latina physician, Dr. Rivera-Cruz has the ambition to provide care for racial and ethnic minority groups and to have an impact within the Hispanic community. She would like to be an advocate from her community by improving healthcare access, medical care and at the same time improving Latinx research representation in reproductive medicine.
Journal article
Preimplantation genetic testing for polygenic disorders (PGT-P) has been commercially available since 2019. PGT-P makes use of polygenic risk scores for conditions which are multifactorial and are significantly influenced by environmental and lifestyle factors. If current predictions are accurate, then absolute risk reductions range from about 0.02% to 10.1%, meaning that between 10 and 5,000 in vitro fertilization patients would need to be tested with PGT-P to prevent one offspring from...
Journal article
Genomic sequencing has been proposed as a strategy to expand newborn screening. Perspectives on genomic newborn screening from parents of diverse racial, ethnic, and socioeconomic backgrounds are needed to shape equitable implementation of this modality. We conducted 20 semi-structured interviews (15 English, 5 Spanish) and seven focus groups (4 English, 3 Spanish) with parents from diverse backgrounds to assess their perspectives regarding which disorders and variants might be screened, data...